Surgery Partners, Inc.

1. 01

   0.9% below its 52-week high

   Closed at $23.16 on 4 Nov 2026: 0.9% below the 52-week high of $23.37 (27 Oct 2026) and 103.0% above the low of $11.41 (30 Mar 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

2. 02

   Behind SPY and its sector fund XLV over 1 year

   1 month: +72.7% (SPY −1.6%, XLV +13.5%). 3 months: +51.2% (SPY −0.4%, XLV +15.5%). 1 year: +5.3% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: SGRY, SPY and XLV · as of 4 Nov 2026

3. 03

   Above its 50- and 200-day averages

   The 4 Nov 2026 close of $23.16 was 47.8% above its 50-day average ($15.67) and 57.2% above its 200-day average ($14.74). It has closed above the 200-day for 17 sessions, since 13 Oct 2026. The 50-day average crossed above the 200-day on 27 Oct 2026, 6 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

4. 04

   10.3 days to cover short interest

   14.3M shares were sold short at the 15 Oct 2026 settlement, 10.9% of the 130.9M shares outstanding; covering them would take 10.3 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

5. 05

   RSI(14) at 85.3, 70 or above

   The 14-session relative strength index closed at 85.3 on 4 Nov 2026, its 8th session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.

   Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026

At the 4 Nov 2026 close